Gender difference in human papillomarvirus infection for non-small cell lung cancer in Taiwan

Ya Wen Cheng, Hui Ling Chiou, Jung Ta Chen, Ming Chih Chou, Torng Sen Lin, Wu Wei Lai, Chih Yi Chen, Yi Yu Tsai, Huei Lee

Research output: Contribution to journalArticle

34 Citations (Scopus)

Abstract

Our previous reports have indicated that high risk human papillomarvirus (HPV) 16/18 were much more frequently detected in lung tumors of female patients as compared to that of male patients and HPV 16/18 in lung tumors were evolutionally correlated with those in blood circulation. In the other hand, it is well known that HPV 6/11 are frequently associated with upper aerodigestive and respiratory diseases. HPV 6/11 DNA were detected in lung tumors by nested PCR and in situ hybridization to investigate if any difference in prevalent types of HPV exists between genders. Our data showed that HPV 6 infection was detected in 28.4% (40 of 141) lung tumors, which was significantly higher than that in non-cancer controls (1.7%, 1 of 60; P <0.0001), however, such high prevalence was not observed for HPV 11. Among studied clinico-pathological parameters, HPV 6 infection was significantly related with gender (P = 0.002) and smoking status (P = 0.014). After being stratified by gender and smoking status, HPV 6 infection rate in lung tumors of non-smoking male patients was much higher than that in non-smoking female patients (33.3% versus 11.1%; P = 0.023), but no difference between smoking and non-smoking male patients (38.1% versus 33.3%). With adjustments for age, tumor type, and tumor stage, smoking male lung cancer patients had a much higher OR value (OR, 7.35; 95%CI, 2.11-25.58) for HPV 6 infection compared with 3.93 (95% CI, 1.17-13.12) of non-smoking male patients. Moreover, a higher prevalence of HPV 6 was detected in lung tumors of smoking male patients with early tumor stage than those with advanced stages (P = 0.008), but not in non-smoking male and female patients. A higher prevalence of HPV 6 in male lung cancer patients, as compared with female lung cancer patients, indicating not only different HPV infection routes for different genders, but also that HPV 6 infections may act as a prospective early risk marker of lung cancer for smoking male patients in Taiwan.

Original languageEnglish
Pages (from-to)165-170
Number of pages6
JournalLung Cancer
Volume46
Issue number2
DOIs
Publication statusPublished - Nov 2004
Externally publishedYes

Fingerprint

Taiwan
Non-Small Cell Lung Carcinoma
Infection
Smoking
Neoplasms
Lung
Lung Neoplasms
Blood Circulation
In Situ Hybridization
Hand

Keywords

  • Human papillomavirus
  • Non-small cell lung cancer

ASJC Scopus subject areas

  • Oncology

Cite this

Cheng, Y. W., Chiou, H. L., Chen, J. T., Chou, M. C., Lin, T. S., Lai, W. W., ... Lee, H. (2004). Gender difference in human papillomarvirus infection for non-small cell lung cancer in Taiwan. Lung Cancer, 46(2), 165-170. https://doi.org/10.1016/j.lungcan.2004.03.023

Gender difference in human papillomarvirus infection for non-small cell lung cancer in Taiwan. / Cheng, Ya Wen; Chiou, Hui Ling; Chen, Jung Ta; Chou, Ming Chih; Lin, Torng Sen; Lai, Wu Wei; Chen, Chih Yi; Tsai, Yi Yu; Lee, Huei.

In: Lung Cancer, Vol. 46, No. 2, 11.2004, p. 165-170.

Research output: Contribution to journalArticle

Cheng, YW, Chiou, HL, Chen, JT, Chou, MC, Lin, TS, Lai, WW, Chen, CY, Tsai, YY & Lee, H 2004, 'Gender difference in human papillomarvirus infection for non-small cell lung cancer in Taiwan', Lung Cancer, vol. 46, no. 2, pp. 165-170. https://doi.org/10.1016/j.lungcan.2004.03.023
Cheng, Ya Wen ; Chiou, Hui Ling ; Chen, Jung Ta ; Chou, Ming Chih ; Lin, Torng Sen ; Lai, Wu Wei ; Chen, Chih Yi ; Tsai, Yi Yu ; Lee, Huei. / Gender difference in human papillomarvirus infection for non-small cell lung cancer in Taiwan. In: Lung Cancer. 2004 ; Vol. 46, No. 2. pp. 165-170.
@article{ed5fca0e851d4742b2dcba27ac40a84f,
title = "Gender difference in human papillomarvirus infection for non-small cell lung cancer in Taiwan",
abstract = "Our previous reports have indicated that high risk human papillomarvirus (HPV) 16/18 were much more frequently detected in lung tumors of female patients as compared to that of male patients and HPV 16/18 in lung tumors were evolutionally correlated with those in blood circulation. In the other hand, it is well known that HPV 6/11 are frequently associated with upper aerodigestive and respiratory diseases. HPV 6/11 DNA were detected in lung tumors by nested PCR and in situ hybridization to investigate if any difference in prevalent types of HPV exists between genders. Our data showed that HPV 6 infection was detected in 28.4{\%} (40 of 141) lung tumors, which was significantly higher than that in non-cancer controls (1.7{\%}, 1 of 60; P <0.0001), however, such high prevalence was not observed for HPV 11. Among studied clinico-pathological parameters, HPV 6 infection was significantly related with gender (P = 0.002) and smoking status (P = 0.014). After being stratified by gender and smoking status, HPV 6 infection rate in lung tumors of non-smoking male patients was much higher than that in non-smoking female patients (33.3{\%} versus 11.1{\%}; P = 0.023), but no difference between smoking and non-smoking male patients (38.1{\%} versus 33.3{\%}). With adjustments for age, tumor type, and tumor stage, smoking male lung cancer patients had a much higher OR value (OR, 7.35; 95{\%}CI, 2.11-25.58) for HPV 6 infection compared with 3.93 (95{\%} CI, 1.17-13.12) of non-smoking male patients. Moreover, a higher prevalence of HPV 6 was detected in lung tumors of smoking male patients with early tumor stage than those with advanced stages (P = 0.008), but not in non-smoking male and female patients. A higher prevalence of HPV 6 in male lung cancer patients, as compared with female lung cancer patients, indicating not only different HPV infection routes for different genders, but also that HPV 6 infections may act as a prospective early risk marker of lung cancer for smoking male patients in Taiwan.",
keywords = "Human papillomavirus, Non-small cell lung cancer",
author = "Cheng, {Ya Wen} and Chiou, {Hui Ling} and Chen, {Jung Ta} and Chou, {Ming Chih} and Lin, {Torng Sen} and Lai, {Wu Wei} and Chen, {Chih Yi} and Tsai, {Yi Yu} and Huei Lee",
year = "2004",
month = "11",
doi = "10.1016/j.lungcan.2004.03.023",
language = "English",
volume = "46",
pages = "165--170",
journal = "Lung Cancer",
issn = "0169-5002",
publisher = "Elsevier Ireland Ltd",
number = "2",

}

TY - JOUR

T1 - Gender difference in human papillomarvirus infection for non-small cell lung cancer in Taiwan

AU - Cheng, Ya Wen

AU - Chiou, Hui Ling

AU - Chen, Jung Ta

AU - Chou, Ming Chih

AU - Lin, Torng Sen

AU - Lai, Wu Wei

AU - Chen, Chih Yi

AU - Tsai, Yi Yu

AU - Lee, Huei

PY - 2004/11

Y1 - 2004/11

N2 - Our previous reports have indicated that high risk human papillomarvirus (HPV) 16/18 were much more frequently detected in lung tumors of female patients as compared to that of male patients and HPV 16/18 in lung tumors were evolutionally correlated with those in blood circulation. In the other hand, it is well known that HPV 6/11 are frequently associated with upper aerodigestive and respiratory diseases. HPV 6/11 DNA were detected in lung tumors by nested PCR and in situ hybridization to investigate if any difference in prevalent types of HPV exists between genders. Our data showed that HPV 6 infection was detected in 28.4% (40 of 141) lung tumors, which was significantly higher than that in non-cancer controls (1.7%, 1 of 60; P <0.0001), however, such high prevalence was not observed for HPV 11. Among studied clinico-pathological parameters, HPV 6 infection was significantly related with gender (P = 0.002) and smoking status (P = 0.014). After being stratified by gender and smoking status, HPV 6 infection rate in lung tumors of non-smoking male patients was much higher than that in non-smoking female patients (33.3% versus 11.1%; P = 0.023), but no difference between smoking and non-smoking male patients (38.1% versus 33.3%). With adjustments for age, tumor type, and tumor stage, smoking male lung cancer patients had a much higher OR value (OR, 7.35; 95%CI, 2.11-25.58) for HPV 6 infection compared with 3.93 (95% CI, 1.17-13.12) of non-smoking male patients. Moreover, a higher prevalence of HPV 6 was detected in lung tumors of smoking male patients with early tumor stage than those with advanced stages (P = 0.008), but not in non-smoking male and female patients. A higher prevalence of HPV 6 in male lung cancer patients, as compared with female lung cancer patients, indicating not only different HPV infection routes for different genders, but also that HPV 6 infections may act as a prospective early risk marker of lung cancer for smoking male patients in Taiwan.

AB - Our previous reports have indicated that high risk human papillomarvirus (HPV) 16/18 were much more frequently detected in lung tumors of female patients as compared to that of male patients and HPV 16/18 in lung tumors were evolutionally correlated with those in blood circulation. In the other hand, it is well known that HPV 6/11 are frequently associated with upper aerodigestive and respiratory diseases. HPV 6/11 DNA were detected in lung tumors by nested PCR and in situ hybridization to investigate if any difference in prevalent types of HPV exists between genders. Our data showed that HPV 6 infection was detected in 28.4% (40 of 141) lung tumors, which was significantly higher than that in non-cancer controls (1.7%, 1 of 60; P <0.0001), however, such high prevalence was not observed for HPV 11. Among studied clinico-pathological parameters, HPV 6 infection was significantly related with gender (P = 0.002) and smoking status (P = 0.014). After being stratified by gender and smoking status, HPV 6 infection rate in lung tumors of non-smoking male patients was much higher than that in non-smoking female patients (33.3% versus 11.1%; P = 0.023), but no difference between smoking and non-smoking male patients (38.1% versus 33.3%). With adjustments for age, tumor type, and tumor stage, smoking male lung cancer patients had a much higher OR value (OR, 7.35; 95%CI, 2.11-25.58) for HPV 6 infection compared with 3.93 (95% CI, 1.17-13.12) of non-smoking male patients. Moreover, a higher prevalence of HPV 6 was detected in lung tumors of smoking male patients with early tumor stage than those with advanced stages (P = 0.008), but not in non-smoking male and female patients. A higher prevalence of HPV 6 in male lung cancer patients, as compared with female lung cancer patients, indicating not only different HPV infection routes for different genders, but also that HPV 6 infections may act as a prospective early risk marker of lung cancer for smoking male patients in Taiwan.

KW - Human papillomavirus

KW - Non-small cell lung cancer

UR - http://www.scopus.com/inward/record.url?scp=4944256906&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=4944256906&partnerID=8YFLogxK

U2 - 10.1016/j.lungcan.2004.03.023

DO - 10.1016/j.lungcan.2004.03.023

M3 - Article

VL - 46

SP - 165

EP - 170

JO - Lung Cancer

JF - Lung Cancer

SN - 0169-5002

IS - 2

ER -